Sensyne Health Share Discussion Threads

[mrc2u] 22/1/2020 09:04

Good case of a journo stating the bleeding obvious about historic numbers in a start upSales could have been ten times higher and loss halved but the historics would still not justify much more than, say, a GBP10m valuation per "the figures"This is investment in the future and if the future happens as the broker sees it, the shares are worth 260p todaySame journo does have it in for management re the IPO bonuses and I quite agree with him on thatMrC

[cottoner] 22/1/2020 08:38

Also from The Times article

"But despite the shares rising 2 per cent on the half-year results, there was nothing in the figures to remotely justify the 260p target price of Liberum, Sensyne’s cheerleading new broker"

[the stigologist] 22/1/2020 08:24

Good brokers with US reach

[mrc2u] 22/1/2020 08:24

Afraid not. Quoted in this morning's Times: will let you know if manage to get hold of a copy

[tsmith2] 22/1/2020 07:59

Have you link

[mrc2u] 22/1/2020 07:58

Liberum, new joint broker, have price target of 260pThat's a five bagger from these levelsMrC

[pugugly] 21/1/2020 16:41

The - Stig- Thanks - Managed to log in using Microsoft Edge - The webcast did not seem to like Firefox. Have to go out - something to listen to/watch later

[the stigologist] 21/1/2020 16:25

Had no problem using Chrome OS

Only seen first few minutes. Very bullish so far.

[pugugly] 21/1/2020 16:24

Anyone else having problems accessing the web-cast - Cannot get the audio - just presentation slides basically repeating the same words as the published report-

[rambutan2] 21/1/2020 15:54

Today’s analyst presenation webcast:

[rambutan2] 21/1/2020 15:51

Its cutting edge AI comes direct from world leading uni research:

[tsmith2] 21/1/2020 12:42

Like what I'm hearing on the webcast

[the stigologist] 21/1/2020 11:41

Private UK Unicorns in AI biotech

Benevolent AI £1 Billion +
ExScientia $1 Billion +

Publicly listed UK AI biotech comps

RENX £200m+
SENS £60m+
ETX £10m
PYC £2m

PYC and ETX are on any measure massively undervalued

[tsmith2] 21/1/2020 11:32

Codswallop

[mrc2u] 21/1/2020 11:03

>>gilesyDisagree that most CEOs would have been sacked because of SENS share price performance. They raised a stack of cash at IPO to pursue a plan and are getting on with it. They claim up front to have hit all the 24 month objectives from IPO early. No reason to fire a CEO for setting out a plan, getting it funded and then delivering against it. The bonus shambles is the only reason so far to fire Drayson and he has at least tried to deploy some fig leaves on thatSENS shares down from 175p to 50p giving a market cap of around GBP60m. Worth looking at private company Benevolent AI, where Woodford also had a big stake. Its value on latest raise was halved from USD2bn to USD1bn. Latest results show revenue of GBP6m and cash consumed if GBP50m. If SENS does get revenues north of GBP2m, which looks likely, and burns about 15m it ought to be worth more than one twelfth of Benevolent after a huge crash in Benevolent's valie. It would also still have 18 months to two years cash left with any additional revenues extending the runwayYes it's hard to value this. You have merely shown that it is easy to troll itMrC

[zulu_principle] 21/1/2020 10:59

Added a few more over the past couple of trading sessions but not this morning (holding fire now until after this afternoon's analyst session). Feeling a little over-invested but generally happy with this morning's interims although the lack of clearer guidance regarding revenues was disappointing.

Edit at 11:33 - having second-thoughts, decided to be ultra-cautious and sold my 11,335 from last week for a modest profit. Made nervous by last year's forecast for 2020 of £2.4m turnover now becoming "significant visibility of a minimum GBP2m" followed by the Group "continues to pursue deals with pharmaceutical companies, however, the timing and structure of such deals remains hard to predict" (a statement of the bleedin' obvious).

The further comment that "the Board is planning for a shift in the Group's anticipated revenue mix with a more visible and significant proportion expected from our work with Cognizant and Agorai in software products" also makes me nervous when these products have yet to receive regulatory approval in the US.

Still holding a decent number and will wait and see what happens this afternoon. Just my (probably over-cautious) current view - as always DYOR.

[gilesy] 21/1/2020 10:05

most CEO's would have been sacked months ago based on the dismal share performance
but he owns most of the shares so that wont happen of course
wouldnt touch with a bargepole myself but as ever DYOR guys

[tsmith2] 21/1/2020 09:54

Clearly your are up to speed with matters

[gilesy] 21/1/2020 09:49

that was the salary figure stated in the last annual accounts

[gilesy] 21/1/2020 09:43

float price July 2018 was 175p
now worth 50p
run by ex labour politician who pays himself 1.3 million a year in salary
cash burn at fast rate
minimal revenue , zero profit , lots of grand promises naturally
cant understand how this is a 60 million company (except it has 37 million cash which its burning through)
not a holder (thank god)

good luck to those who are optimistic but the cold facts are not good

[tsmith2] 21/1/2020 09:37

Also given how highly the NHS is regarded around the world it wouldn't at all surprise me if they acted for replicated this internationally

[tsmith2] 21/1/2020 09:36

You would expect such cash burn at such a stage in such a company?The revenue streams are now coming online with partnerships and JV starting to come through..they are in a very hot tech spot and something in its infancy with huge growth opportunities and the relationship with the NHS as an intermediary could be delightfully sweet spot

[the stigologist] 21/1/2020 09:31

The cash burn is atrocious. To focus on £2m of Revenue when they're burning £10m a year isn't a great look.

However we shouldn't let that detract from bigger picture story which they've reminded the Market about today with the separate RNS on utilising NHS data and the data mining/ML/AI potential.

To be honest PYC (£2m Mkt Cap) and ETX (£10m Mkt Cap) give purer 'options' on the AI/ML market growth.

SENS is more of a nearer term technical overhang play in my book.

PYC is running around cash break-even. Also a neighbour of SENS on Oxford Science Park so potential for collaboration going forward.

[tsmith2] 21/1/2020 09:27

Overhang possibly cleared I'll be listening to the Webcast.Given the statement re: share price in announcement I'll be looking for directors to put money where mouth is too